Navigation Links
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Date:7/12/2011

neron's product and drug candidates, competing drugs that may be superior to Regeneron's product and drug candidates, uncertainty of market acceptance of Regeneron's product and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any license or collaboration agreement, including Regeneron's agreements with the Sanofi Group and Bayer HealthCare, to be canceled or terminated without any product success, and risks associated with third party intellectual property and pending or future litigation relating thereto.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2010 and Form 10-Q for the quarter ended March 31, 2011.  Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise, unless required by law.ContactsSanofi:Global Product Communications Corporate Media RelationsIngrid Gorg-Armbrecht

Marisol PeronTel: +33 (0) 1 53 77 46 25

Tel: +33 (0) 1 53 77 45 02Mobile: + 33(0) 6 38 10 50 87

Mobile: +33 (0) 6 08 18 94 78E-mail:ingrid.goerg-armbrecht@sanofi.com

E-mail: marisol.peron@sanofi.comRegeneron:Investor Relations Media RelationsMichael Aberman, M.D.

Peter DworkinTel: 1 (914) 345-7799

Tel: 1 (914) 345-7640michael.aberman@regeneron.com

peter.dworkin@regeneron.com
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
2. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
3. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
4. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
5. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
6. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
7. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
8. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
9. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
10. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
11. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. ... the closing of its offering of $125 million aggregate ... (the "Notes").  The Notes were offered and sold only ... the Securities Act of 1933, as amended (the "Securities ... fixed rate of 3.75% per year, payable semiannually in ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "MEMS Gyroscopes Analog Devices ADIS16136 ... report to their offering. ... tactical grade applications made a lot of progress ... reliability. They are now accepted in high-reliability environments, ...
(Date:12/15/2014)... and HERZLIYA PITUACH, Israel , Dec. ... IMNP ) announced today that its Board of ... succeeding Dr. Daniel Teper who continues as Chief ... of Immune,s Board of Directors since 2013. Immune,s ... delighted to represent the interest of shareholders and to continue ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... Retirement Living TV (RLTV), the only network dedicated to ... Body Health on Thursday, November 19(th) at 8:00 pm ... to the center of public policy, award-winning medical journalist Kevin ... and advice tied to complementary and integrative medicine. He ...
... , WOODCLIFF LAKE, N.J., Nov. 16 Par Pharmaceutical ... Day from 9:00am to 12:00pm EST on December 3, 2009 at ... Executive Officer, Patrick G. LePore, and other members of the senior ... current products and pipelines, and business outlook to analysts and investors. ...
Cached Medicine Technology:Retirement Living TV Premieres Season Two of Whole Body Health 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Need for continuing, open dialogue remains , ... While health care reform legislation currently in Congress addresses many of the ... a number of issues including the public health insurance option and the ... "It is our objective to be a constructive partner with Congress and ...
... ... 1 August 2009 all doctors in training should be working a 48-hour week. Aimed at ... leaders are also seeing this move as a great opportunity, writes Robert Stiff MD Team24. ... (PRWeb UK) July ...
... , , , ... Inc. (PSH), a Los Angeles-based manufacturing and distribution corporation is proud to ... balm product division. Burner Balm, a natural lip balm that claims ... dietary, energy drink and lip balm arena. The product line is turning ...
... the heart , WEDNESDAY, July 22 (HealthDay News) -- ... one day be able to reverse the electrical problems in ... , Researchers grew "beating" cells with properties similar to the ... fat tissue of mice. They then injected them into rodents ...
... FT. MYERS, Fla., July 22 NeoGenomics, Inc. (NASD OTC ... quarter 2009 financial results on Tuesday, July 28, 2009. , ... call to discuss their Q2 09 results on July 28, 2009, at ... (201) 689-8049 (international) at least five minutes prior to the call. ...
... , AUSTIN, Texas, July 22 There are 125,000 ... solutions are the 125,000 NPs practicing in the United States today. For ... specialty care needs of their patients with the highest level of ... care provider, just as others may select MDs or DOs. , ...
Cached Medicine News:Health News:Michigan State Medical Society Weighs in on Proposed Federal Health Care Reform Legislation 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 3Health News:Burner Balm Gets International Attention 2Health News:Stem Cells Used for 'Biological Pacemaker' 2Health News:NeoGenomics Schedules Its Q2 2009 Earnings Release for July 28, 2009 2Health News:125,000 Solutions to the Primary Care Shortage - Nurse Practitioners (NPs) 2
Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....
Shafts angled 45 degrees, 10 mm from tip to bend. Tips curved with 0.5 mm, 1 x 2 teeth. Serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
Smooth pointed tips open to 3.0 mm. Cross action curved shafts. Tip to Angle Length: 12.0 mm. Round handle....
Medicine Products: